We are live on ! Find out more
ALDR

Alder Biopharmaceuticals
ALDR

Delisted

ALDR was delisted on the 21st of October, 2019.

127 hedge funds and large institutions have $1.69B invested in Alder Biopharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 49 funds opening new positions, 48 increasing their positions, 29 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

345% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 11

167% more capital invested

Capital invested by funds: $635M → $1.69B (+$1.06B)

100% more funds holding in top 10

Funds holding in top 10: 24 (+2)

66% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 29

43% more funds holding

Funds holding: 89127 (+38)

59% less call options, than puts

Call options by funds: $2.66M | Put options by funds: $6.49M

Holders
127
Holders Change
+38
Holders Change %
+42.7%
% of All Funds
3.42%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.11%
New
49
Increased
48
Reduced
29
Closed
11
Calls
$2.66M
Puts
$6.49M
Net Calls
-$3.83M
Net Calls Change
-$3.83M
Name Holding Trade Value Shares
Change
Change in
Stake
CS
51
Credit Suisse
Switzerland
$3.03M +$756K +20,794 +57%
PP
52
PDT Partners
New York
$2.83M +$435K +11,958 +29%
Susquehanna International Group
53
Susquehanna International Group
Pennsylvania
$2.46M +$677K +18,606 +67%
Wellington Management Group
54
Wellington Management Group
Massachusetts
$2.39M -$6.66M -183,000 -80%
T. Rowe Price Associates
55
T. Rowe Price Associates
Maryland
$2.28M +$1.56M +43,000 New
NIP
56
Nicholas Investment Partners
California
$2.24M -$491K -13,508 -24%
CS
57
Candriam SCA
Luxembourg
$2.12M +$1.45M +40,000 New
PAMU
58
Pictet Asset Management (UK)
United Kingdom
$2.05M -$676K -18,600 -30%
AA
59
ALPS Advisors
Colorado
$1.99M +$704K +19,367 +106%
California State Teachers Retirement System (CalSTRS)
60
California State Teachers Retirement System (CalSTRS)
California
$1.99M +$696K +19,138 +104%
Mirae Asset Global Investments
61
Mirae Asset Global Investments
South Korea
$1.9M +$392K +10,775 +43%
Ameriprise
62
Ameriprise
Minnesota
$1.81M +$1.24M +34,125 New
ProShare Advisors
63
ProShare Advisors
Maryland
$1.74M +$16.1K +443 +1%
BKBG
64
BHF Kleinwort Benson Group
Belgium
$1.7M +$1.4M +38,573 New
Charles Schwab
65
Charles Schwab
California
$1.58M +$474K +13,046 +78%
AQR Capital Management
66
AQR Capital Management
Connecticut
$1.38M +$950K +26,134 New
GH
67
GAM Holding
Switzerland
$1.38M +$949K +26,100 New
Swiss National Bank
68
Swiss National Bank
Switzerland
$1.29M +$884K +24,300 New
Allianz Asset Management
69
Allianz Asset Management
Germany
$1.2M +$821K +22,570 New
ACH
70
ArrowMark Colorado Holdings
Colorado
$1.19M -$175K -4,810 -18%
EI
71
EAM Investors
California
$1.19M -$464K -12,762 -36%
HLA
72
Hamilton Lane Advisors
Pennsylvania
$1.18M +$813K +22,359 New
New York State Common Retirement Fund
73
New York State Common Retirement Fund
New York
$1.11M +$640K +17,594 +517%
SO
74
STRS Ohio
Ohio
$1.08M -$160K -4,400 -18%
Neuberger Berman Group
75
Neuberger Berman Group
New York
$1.06M +$727K +20,000 New

ALDR Hedge Fund Activity: Q2 2015 in Review

127 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Alder Biopharmaceuticals (ALDR) for Q2 2015, worth a combined $1.69B — up 167% from $635M a quarter earlier.

Buyers outnumbered sellers: 49 funds opened new ALDR positions and 11 closed out — a net gain of 38 holders — while 48 added to existing stakes and 29 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $204M. The largest seller was Novo Holdings A/S, cutting an estimated $45.5M.

  • 127 institutional investors held Alder Biopharmaceuticals (ALDR) as of Q2 2015, up from 89 in Q1 2015.
  • Funds reported $1.69B of Alder Biopharmaceuticals stock for Q2 2015, up 167% quarter-over-quarter.
  • 49 funds opened new Alder Biopharmaceuticals positions in Q2 2015 and 11 closed out, a net change of +38 holders.
  • The largest Alder Biopharmaceuticals buyer in Q2 2015 was Fidelity Investments, an estimated $204M added.
  • The largest Alder Biopharmaceuticals seller in Q2 2015 was Novo Holdings A/S, an estimated $45.5M sold.

Based on aggregated 13F filings for Q2 2015.